197 related articles for article (PubMed ID: 32573332)
1. Biologically-based modeling of radiation risk and biomarker prevalence for papillary thyroid cancer in Japanese a-bomb survivors 1958-2005.
Kaiser JC; Misumi M; Furukawa K
Int J Radiat Biol; 2021; 97(1):19-30. PubMed ID: 32573332
[TBL] [Abstract][Full Text] [Related]
2. Papillary Thyroid Carcinoma in Ukraine After Chernobyl and in Japan After Fukushima: Different Histopathological Scenarios.
Bogdanova TI; Saenko VA; Hashimoto Y; Hirokawa M; Zurnadzhy LY; Hayashi T; Ito M; Iwadate M; Mitsutake N; Rogounovitch TI; Sakamoto A; Naganuma H; Miyauchi A; Tronko MD; Thomas G; Yamashita S; Suzuki S
Thyroid; 2021 Sep; 31(9):1322-1334. PubMed ID: 33143557
[No Abstract] [Full Text] [Related]
3. Integration of a radiation biomarker into modeling of thyroid carcinogenesis and post-Chernobyl risk assessment.
Kaiser JC; Meckbach R; Eidemüller M; Selmansberger M; Unger K; Shpak V; Blettner M; Zitzelsberger H; Jacob P
Carcinogenesis; 2016 Dec; 37(12):1152-1160. PubMed ID: 27729373
[TBL] [Abstract][Full Text] [Related]
4. Gene signature of the post-Chernobyl papillary thyroid cancer.
Handkiewicz-Junak D; Swierniak M; Rusinek D; Oczko-Wojciechowska M; Dom G; Maenhaut C; Unger K; Detours V; Bogdanova T; Thomas G; Likhtarov I; Jaksik R; Kowalska M; Chmielik E; Jarzab M; Swierniak A; Jarzab B
Eur J Nucl Med Mol Imaging; 2016 Jul; 43(7):1267-77. PubMed ID: 26810418
[TBL] [Abstract][Full Text] [Related]
5. RET/PTC rearrangements preferentially occurred in papillary thyroid cancer among atomic bomb survivors exposed to high radiation dose.
Hamatani K; Eguchi H; Ito R; Mukai M; Takahashi K; Taga M; Imai K; Cologne J; Soda M; Arihiro K; Fujihara M; Abe K; Hayashi T; Nakashima M; Sekine I; Yasui W; Hayashi Y; Nakachi K
Cancer Res; 2008 Sep; 68(17):7176-82. PubMed ID: 18757433
[TBL] [Abstract][Full Text] [Related]
6. Contribution of ATM and FOXE1 (TTF2) to risk of papillary thyroid carcinoma in Belarusian children exposed to radiation.
Damiola F; Byrnes G; Moissonnier M; Pertesi M; Deltour I; Fillon A; Le Calvez-Kelm F; Tenet V; McKay-Chopin S; McKay JD; Malakhova I; Masyakin V; Cardis E; Lesueur F; Kesminiene A
Int J Cancer; 2014 Apr; 134(7):1659-68. PubMed ID: 24105688
[TBL] [Abstract][Full Text] [Related]
7. Dose-dependent expression of CLIP2 in post-Chernobyl papillary thyroid carcinomas.
Selmansberger M; Kaiser JC; Hess J; Güthlin D; Likhtarev I; Shpak V; Tronko M; Brenner A; Abend M; Blettner M; Unger K; Jacob P; Zitzelsberger H
Carcinogenesis; 2015 Jul; 36(7):748-56. PubMed ID: 25957251
[TBL] [Abstract][Full Text] [Related]
8. Risk of cancer associated with low-dose radiation exposure: comparison of results between the INWORKS nuclear workers study and the A-bomb survivors study.
Leuraud K; Richardson DB; Cardis E; Daniels RD; Gillies M; Haylock R; Moissonnier M; Schubauer-Berigan MK; Thierry-Chef I; Kesminiene A; Laurier D
Radiat Environ Biophys; 2021 Mar; 60(1):23-39. PubMed ID: 33479781
[TBL] [Abstract][Full Text] [Related]
9. Comparison of transcriptomic signature of post-Chernobyl and postradiotherapy thyroid tumors.
Ory C; Ugolin N; Hofman P; Schlumberger M; Likhtarev IA; Chevillard S
Thyroid; 2013 Nov; 23(11):1390-400. PubMed ID: 23521174
[TBL] [Abstract][Full Text] [Related]
10. Investigation of the Relationship Between Radiation Dose and Gene Mutations and Fusions in Post-Chernobyl Thyroid Cancer.
Efanov AA; Brenner AV; Bogdanova TI; Kelly LM; Liu P; Little MP; Wald AI; Hatch M; Zurnadzy LY; Nikiforova MN; Drozdovitch V; Leeman-Neill R; Mabuchi K; Tronko MD; Chanock SJ; Nikiforov YE
J Natl Cancer Inst; 2018 Apr; 110(4):371-378. PubMed ID: 29165687
[TBL] [Abstract][Full Text] [Related]
11. A framework for estimating radiation-related cancer risks in Japan from the 2011 Fukushima nuclear accident.
Walsh L; Zhang W; Shore RE; Auvinen A; Laurier D; Wakeford R; Jacob P; Gent N; Anspaugh LR; Schüz J; Kesminiene A; van Deventer E; Tritscher A; del Rosarion Pérez M
Radiat Res; 2014 Nov; 182(5):556-72. PubMed ID: 25251702
[TBL] [Abstract][Full Text] [Related]
12. Post-Chernobyl incidence of papillary thyroid cancer among Belgian children less than 15 years of age in April 1986: a 30-year surgical experience.
Michel LA; Donckier J; Rosière A; Fervaille C; Lemaire J; Bertrand C
Acta Chir Belg; 2016 Apr; 116(2):101-13. PubMed ID: 27385297
[TBL] [Abstract][Full Text] [Related]
13. Long-term trend of thyroid cancer risk among Japanese atomic-bomb survivors: 60 years after exposure.
Furukawa K; Preston D; Funamoto S; Yonehara S; Ito M; Tokuoka S; Sugiyama H; Soda M; Ozasa K; Mabuchi K
Int J Cancer; 2013 Mar; 132(5):1222-6. PubMed ID: 22847218
[TBL] [Abstract][Full Text] [Related]
14. Transcriptome network of the papillary thyroid carcinoma radiation marker CLIP2.
Selmansberger M; Michna A; Braselmann H; Höfig I; Schorpp K; Weber P; Anastasov N; Zitzelsberger H; Hess J; Unger K
Radiat Oncol; 2020 Jul; 15(1):182. PubMed ID: 32727620
[TBL] [Abstract][Full Text] [Related]
15. Thyroid Dysfunction and Autoimmune Thyroid Diseases Among Atomic Bomb Survivors Exposed in Childhood.
Imaizumi M; Ohishi W; Nakashima E; Sera N; Neriishi K; Yamada M; Tatsukawa Y; Takahashi I; Fujiwara S; Sugino K; Ando T; Usa T; Kawakami A; Akahoshi M; Hida A
J Clin Endocrinol Metab; 2017 Jul; 102(7):2516-2524. PubMed ID: 28472357
[TBL] [Abstract][Full Text] [Related]
16. CLIP2 as radiation biomarker in papillary thyroid carcinoma.
Selmansberger M; Feuchtinger A; Zurnadzhy L; Michna A; Kaiser JC; Abend M; Brenner A; Bogdanova T; Walch A; Unger K; Zitzelsberger H; Hess J
Oncogene; 2015 Jul; 34(30):3917-25. PubMed ID: 25284583
[TBL] [Abstract][Full Text] [Related]
17. Papillary microcarcinoma of the thyroid among atomic bomb survivors: tumor characteristics and radiation risk.
Hayashi Y; Lagarde F; Tsuda N; Funamoto S; Preston DL; Koyama K; Mabuchi K; Ron E; Kodama K; Tokuoka S
Cancer; 2010 Apr; 116(7):1646-55. PubMed ID: 20120034
[TBL] [Abstract][Full Text] [Related]
18. Effects of radiation and lifestyle factors on risks of urothelial carcinoma in the Life Span Study of atomic bomb survivors.
Grant EJ; Ozasa K; Preston DL; Suyama A; Shimizu Y; Sakata R; Sugiyama H; Pham TM; Cologne J; Yamada M; De Roos AJ; Kopecky KJ; Porter MP; Seixas N; Davis S
Radiat Res; 2012 Jul; 178(1):86-98. PubMed ID: 22631857
[TBL] [Abstract][Full Text] [Related]
19. Association between the increase in incidence of papillary thyroid carcinoma in Crete and exposure to radioactive agents.
Prokopakis EP; Kaprana A; Karatzanis A; Velegrakis GA; Melissas J; Chalkiadakis G
Acta Otorhinolaryngol Ital; 2018 Aug; 38(4):310-315. PubMed ID: 29498716
[TBL] [Abstract][Full Text] [Related]
20. Comparative Histopathologic Analysis of "Radiogenic" and "Sporadic" Papillary Thyroid Carcinoma: Patients Born Before and After the Chernobyl Accident.
Bogdanova TI; Saenko VA; Brenner AV; Zurnadzhy LY; Rogounovitch TI; Likhtarov IA; Masiuk SV; Kovgan LM; Shpak VM; Thomas GA; Chanock SJ; Mabuchi K; Tronko MD; Yamashita S
Thyroid; 2018 Jul; 28(7):880-890. PubMed ID: 29989861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
